OncoRx

by OncoRx
VISIT OFFICIAL WEBSITE →
Disclaimer: This page is an independent third-party listing and is not affiliated with, sponsored by, or endorsed by OncoRx or OncoRx. All product names, logos, and brands are property of their respective owners.

OVERVIEW

AI-powered platform that transforms complex molecular diagnostic reports into actionable, evidence-based insights for oncologists and pharmaceutical companies.

The OncoRx Insights platform is an AI-driven solution designed to revolutionize precision oncology and community cancer care. It accelerates access to the most effective and precise cancer treatments by utilizing AI technology to bridge the relationship between oncologists, pharmaceutical companies, and patients.

For oncologists, the platform acts as a single, trusted hub for diagnostic reports, integrating molecular diagnostic, pathology, and IHC data. Its AI agents create a summary of each patient's history and translate complex Next-Generation Sequencing (NGS) reports into clear, easily consumed visuals and actionable insights, streamlining treatment decisions. A key benefit is the platform's ability to help practices obtain additional revenue by enabling reimbursement using new AMA CPT codes for AI platform usage.

For pharmaceutical companies, OncoRx Insights provides "SMART PHARMA DATA"—unique, near real-time insights that uncover the 'why' behind oncologist treatment decisions, comprehensive patient treatment paths, and data by drug, physician, and practice. This intelligence from the oncologist's treatment decision process allows for improved drug targeting and precisely targeted marketing.

The platform is EMR agnostic, ensuring seamless integration, and is designed for secure, HIPAA-compliant storage and quick access to diagnostic reports.

RATING & STATS

Founded
2022

KEY FEATURES

  • AI-Driven Molecular Diagnostic Report Analysis
  • EMR-Agnostic Integration
  • Real-time Research and Clinical Trial Links
  • Reimbursement Enablement (AMA CPT Codes)
  • Single Portal for All Diagnostic Reports
  • Oncologist Decision Journey Insights (for Pharma)
  • HIPAA Compliant Data Management

PRICING

Model: free
The software is free for community oncology practices, and it helps practices generate additional revenue by enabling reimbursement using new AMA CPT codes for AI platform usage.
FREE TIER

TECHNICAL DETAILS

Deployment: cloud, saas
Platforms: web
🔌 API Available

USE CASES

Accelerating Cancer Treatment DecisionsEnhancing Precision OncologyStreamlining Prior AuthorizationProviding Market Insights for Pharmaceutical Companies

INTEGRATIONS

EMRs (Electronic Medical Records)

COMPLIANCE & SECURITY

Compliance:
HIPAA
Security Features:
  • 🔒Secure Storage
  • 🔒Encryption

SUPPORT & IMPLEMENTATION

Support: email, phone, training
Implementation Time: 1-4 weeks
Target Company Size: small, medium, enterprise
TRAINING AVAILABLE

PROS & CONS

✓ Pros:
  • +Free for oncology practices, with potential for increased revenue via CPT codes
  • +AI-powered translation of complex NGS/pathology reports into actionable visuals
  • +EMR-agnostic integration capability
  • +Provides unique, near real-time data on oncologist decision-making for pharma
✗ Cons:
  • -Relatively new company (Founded 2022)
  • -Limited public information on customer count/scale
  • -Highly niche focus (Oncology only)

ABOUT ONCORX

Other software by OncoRx:
OncoRx-MI (Chemotherapy Order Management (CPOE)Drug-drug interaction checking)

BROWSE SOFTWARE IN DRUG-DRUG INTERACTION CHECKING